What is The 360-Degree Gender Sphere

Women in the bioscience sector continue to be under-represented at higher organizational levels. Only ten percent of the biopharmaceutical industry has female CEOs, and only one company had a board where women outnumbered men. Further, one female CEO exists within the largest pharmaceutical companies: Emma Walmsley of GlaxoSmithKline, and Reshma Kewelramani of Vertex joined in 2020. The bioscience sector is extremely lucrative, where the average female CEO pay is $5.2 million versus the average male earnings of $5.7 million. Diversity at high organizational levels within the bioscience sector is essential. Having women represented at higher organizational levels brings customer perspectives to the strategic decision-making process, provides mentors and sponsors for other women in the organization, and contributes to innovation and creativity. This chapter includes findings from previous research, which showed the barriers encountered “360-Degree Gender Sphere” and the strategies used “Six Strategies to Create Resilience” during career progression by women. There are three modules of this work. The first is an awareness program of the barriers women encounter while ascending in the bioscience sector the 360-degee gender sphere. The second section assesses and accentuates which barriers are most troublesome; and the last segment is “The Six Strategies to Create Resilience Action Plans”. These programs assist females in understanding the barriers they may encounter and the necessary strategies one must take to overcome the peripheral “360-Degree Gender Sphere” and create resilience. The 360-degree gender sphere and the six strategies to create resilience conveys decades of knowledge from successful executives in the healthcare industry.